+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Tigloylgomisin H

SBP04216
66069-55-4
98%
普瑞法
Tigloylgomisin H represents a potential liver cancer prevention agent, it can significantly induce quinone reductase (QR) activity in Hepa1c1c7 mouse hepatocarcinoma cells, it functions as a novel monofunctional inducer that specifically upregulates phase II enzymes through the Nrf2-ARE pathway.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP04216-5mg 5mg
SBP04216-10mg 10mg
SBP04216-20mg 20mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

TNF PTGS2 IL6 IL1B GFAP NFKBIA
TNF NQO1 IL1B SOD1 HMOX1 UGT1A1 ABCC2
NFE2L2 NQO1 SOD1 HMOX1 KEAP1 GCLC
NFE2L2 TNF PTGS2 NQO1 IL6 HMOX1 KEAP1 NFKBIA GCLC UGT1A1

Tigloylgomisin H Related Products

Product drug property prediction parameters

  • 92.6800

  • 4.4122

  • 4.4122

  • .0070

  • 3.1495

  • 9.9946

  • High

  • 90.1847

  • 3.7849

  • No

  • No

  • Yes

  • No

  • No

  • Yes

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes